Bad blood and biologicals the need for new radiopharmaceutical source materials

Nuclear Medicine Communications

Volumn 20, Issue 1, 1999, Pages 1-

  Perkins, Alan C ^a   Frier, Malcolm ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FIBRINOGEN; IODINE 125; POLYMER; POLYPEPTIDE; RADIOPHARMACEUTICAL AGENT; RECOMBINANT PROTEIN;

BACTERIUM CONTAMINATION; BLOOD; DIAGNOSTIC IMAGING; DRUG FORMULATION; EDITORIAL; NUCLEAR MEDICINE; TRANSGENIC ANIMAL;

EID: 0032969694     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199901000-00001     Document Type: Article

References (17)

1. Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
2. Perkins AC, Frier M. Experimental biodistribution studies of 99Tcm recombinant human serum albumin (rHSA): A new generation of radiopharmaceutical. Eur J Nucl Med 1994; 21: 1231-1233.
3. Verbeke K, Ons S, De Roo M, Verbruggen A. Labelling of poly-L-lysine with 99Tcm and evaluation as a possible tracer agent for ventriculography. Eur J Nucl Med 1994; 38 (suppl. 1): 75-78.
4. Perkins AC, Frier M, Pimm MV, Hudecz F. “Tcm-branched-chain polypeptide (BCP): A potential synthetic radiopharmaceutical. J Labelled Compounds Radiopharm (in press).
5. Pimm MV, Perkins AC, Gribben SJ et al. Gamma scintigraphy of inIn-labelled branched chain polypeptides (BCP) with a poly(L-lysine) backbone in mice with mammary carcinoma: Effect of charge on biodistribution and tumour imaging potential. Ann Nucl Med 1995; 9: 247-251.
6. Enser M. Dutch pull the plug on cow cloning. Science 1998; 279: 1444.
7. Duncan R, Dimitrijevic S, Evagorou E. The role of polymer conjugates in the diagnosis and treatment of cancer. STP Pharma Sci 1996; 6: 237-263.
8. Pimm MV, Perkins AC, Hudecz F. Scintigraphic evaluation of the pharmacokinetics of a soluble polymeric drug carrier. Eur J Nucl Med 1992; 19: 449-452.
9. Pimm MV, Perkins AC, Gribben SJ, Hudecz F. Scintigraphic determination of an In-lll-labelled poly (L-lysine) backbone branched polypeptide drug carrier in tumour-bearing mice. J Nucl Biol Med 1994; 38 (suppl. 1): 104-108.
10. Pimm MV, Perkins AC, Strohalm J, Ulbrich K, Duncan R. Gamma scintigraphy of the biodistribution of 1231-labelled N-(2-hydroxypropyl) methacrylamide copolymer-doxoru-bicin conjugates in mice with transplanted melanoma and mammary carcinoma. J Drug Target 1996; 3: 375-385.
11. Pimm MV, Perkins AC, Strohalm J, Ulbrich K, Duncan R. Gamma scintigraphy of a 1231-labelled N-(2-hydroxypro-pyl) methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma. J Drug Target 1996; 3: 385-390.
12. Khaw BA, Kilbanov A, O’Donnell SM et al. Gamma imaging with negatively charge-modified monoclonal antibody: Modification with synthetic polymers. J Nucl Biol Med 1991; 32: 1742-1751.
13. Bogdanov AA, Callahan RJ, Wilkinson RA et al. Synthetic copolymer kit for radionuclide blood-pool imaging. J Nucl Biol Med 1994; 35: 1880-1886.
14. Perkins AC. Polymer diagnostics: The next generation of image contrast agents. J Drug Target (in press).
15. Wiener EC, Brechbiel MW, Brothers H et al. Dendrimer-based metal chelates: A new class of magnetic resonance image contrast agents. Magn Reson Med 1994; 13: 1-8.
16. Schwickert HC, Roberts TPL, Mühler A, Stiskal M, Demsar F, Brasch RC. Angiographic properties of Gd-DTPA-24-cascade-polymer: A new macromolecular MR contrast agent. Eur J Radiol 20: 144-150.
17. Schneider M, Broillet A, Bussat P, Ventrone R. The use of polymeric microballoons as ultrasound contrast agents for liver imaging. Invest Radiol 1994; 29: S149-S151.